Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

668 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Assessing the risk of breast cancer.
Armstrong K, Eisen A, Weber B. Armstrong K, et al. Among authors: eisen a. N Engl J Med. 2000 Feb 24;342(8):564-71. doi: 10.1056/NEJM200002243420807. N Engl J Med. 2000. PMID: 10684916 Review. No abstract available.
Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.
Eisen A, Rebbeck TR, Wood WC, Weber BL. Eisen A, et al. J Clin Oncol. 2000 May;18(9):1980-95. doi: 10.1200/JCO.2000.18.9.1980. J Clin Oncol. 2000. PMID: 10784640 Review.
Recent advances in breast cancer biology.
Eisen A, Weber BL. Eisen A, et al. Curr Opin Oncol. 1998 Nov;10(6):486-91. doi: 10.1097/00001622-199811000-00002. Curr Opin Oncol. 1998. PMID: 9818225 Review.
Prophylactic mastectomy--the price of fear.
Eisen A, Weber BL. Eisen A, et al. N Engl J Med. 1999 Jan 14;340(2):137-8. doi: 10.1056/NEJM199901143400209. N Engl J Med. 1999. PMID: 9887166 No abstract available.
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL. Rebbeck TR, et al. Among authors: eisen a. J Natl Cancer Inst. 1999 Sep 1;91(17):1475-9. doi: 10.1093/jnci/91.17.1475. J Natl Cancer Inst. 1999. PMID: 10469748
Prophylactic mastectomy for women with BRCA1 and BRCA2 mutations--facts and controversy.
Eisen A, Weber BL. Eisen A, et al. N Engl J Med. 2001 Jul 19;345(3):207-8. doi: 10.1056/NEJM200107193450309. N Engl J Med. 2001. PMID: 11463017 No abstract available.
Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.
Levine MN, Julian JA, Bedard PL, Eisen A, Trudeau ME, Higgins B, Bordeleau L, Pritchard KI. Levine MN, et al. Among authors: eisen a. J Clin Oncol. 2016 Apr 1;34(10):1065-71. doi: 10.1200/JCO.2015.62.8503. Epub 2015 Nov 23. J Clin Oncol. 2016. PMID: 26598746
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Rebbeck TR, Friebel T, Wagner T, Lynch HT, Garber JE, Daly MB, Isaacs C, Olopade OI, Neuhausen SL, van 't Veer L, Eeles R, Evans DG, Tomlinson G, Matloff E, Narod SA, Eisen A, Domchek S, Armstrong K, Weber BL; PROSE Study Group. Rebbeck TR, et al. Among authors: eisen a. J Clin Oncol. 2005 Nov 1;23(31):7804-10. doi: 10.1200/JCO.2004.00.8151. Epub 2005 Oct 11. J Clin Oncol. 2005. PMID: 16219936
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.
Metcalfe KA, Lynch HT, Ghadirian P, Tung N, Olivotto IA, Foulkes WD, Warner E, Olopade O, Eisen A, Weber B, McLennan J, Sun P, Narod SA. Metcalfe KA, et al. Among authors: eisen a. Gynecol Oncol. 2005 Jan;96(1):222-6. doi: 10.1016/j.ygyno.2004.09.039. Gynecol Oncol. 2005. PMID: 15589605
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
Chlebowski RT, Col N, Winer EP, Collyar DE, Cummings SR, Vogel VG 3rd, Burstein HJ, Eisen A, Lipkus I, Pfister DG; American Society of Clinical Oncology Breast Cancer Technology Assessment Working Group. Chlebowski RT, et al. Among authors: eisen a. J Clin Oncol. 2002 Aug 1;20(15):3328-43. doi: 10.1200/JCO.2002.06.029. J Clin Oncol. 2002. PMID: 12149307 Review.
668 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback